📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
NEUTRAL
TOTAL VIEWS
146
TEM Latest News & AI Sentiment Analysis
0 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 9 ARTICLES
Is Tempus AI Stock a Buy After Its CEO Sold 250,000 Shares?
Tempus AI CEO executed a routine share sale of 250,000 shares under a pre-established trading plan, representing approximately 4% of his...
Tempus AI, Inc. (TEM) Q2 2026 Earnings Call Transcript
Tempus AI (TEM) released Q2 2026 earnings results via earnings call transcript. The limited summary data available suggests standard...
Tempus AI Acquires Personalis: Why Both Stocks Are A Buy Now (NASDAQ:TEM)
Tempus AI's acquisition of Personalis represents a significant consolidation play in the precision oncology diagnostics space. The deal...
Personalis, Inc. (PSNL) Tempus AI, Inc. - M&A Call - Slideshow (NASDAQ:PSNL) 2026-07-20
Personalis (PSNL) and Tempus AI (TEM) announced a merger combination, representing a significant consolidation in the genomic sequencing...
Tempus AI Bets on MRD Testing Growth With Personalis Acquisition
Tempus AI announced a strategic acquisition of Personalis to consolidate leadership in minimal residual disease (MRD) testing, a...
Tempus AI to acquire cancer-monitoring firm Personalis for $1.5B
Tempus AI's $1.5 billion acquisition of Personalis signals accelerating consolidation in the oncology diagnostics sector, where...
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
Tempus AI (TEM) announced a definitive acquisition of Personalis (PSNL), a genomics-focused precision oncology company. This deal...
Tempus AI: Building Ultimate Healthcare Data Dominance (NASDAQ:TEM)
Tempus AI (TEM) is positioned as a high-growth healthcare data and analytics platform, with the headline framing it as achieving data...
Tempus AI: The Market Is Betting On An Inflection I Can't Yet See (NASDAQ:TEM)
Tempus AI (TEM) faces a valuation disconnect between market pricing and fundamental metrics. The analyst identifies a fair value...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice